Immunoprecise Antibodies Ltd (IPA) — Cash Flow Reinvestment Rate
Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Reinvestment Rate of 3.25x as of October 2020, reinvesting $1.43 Million (capex $715.21K plus investments $-715.21K) from operating cash flow of $440.23K. Check IPA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Immunoprecise Antibodies Ltd Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Immunoprecise Antibodies Ltd across 1 annual periods. Explore Immunoprecise Antibodies Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Immunoprecise Antibodies Ltd (2016–2016)
Year-by-year capital reinvestment analysis for Immunoprecise Antibodies Ltd. For live market cap and broader valuation context, see how much is Immunoprecise Antibodies Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.06x | $17.48K | $284.09K | $17.48K | — |